GODREJAGRO

- Allotment of 51,423 equity shares (face value ₹10) to eligible employees under ESGS 2018, realizing ₹5,14,230. - Post-allotment, paid-up equity share capital increased to 19,24,11,390 shares. - Noted lapse of 10,329 stock options due to cessation of employment.

- Godrej Agrovet Limited allotted 51,423 equity shares of ₹10 each to eligible employees under the ESGS 2018, approved on August 25, 2026. - Post-allotment, the paid-up equity share capital increased to 19,24,11,390 shares. - The company also noted the lapse of 10,329 stock options granted under ESGS 2018 due to cessation of employment.

- Q1 FY27 consolidated sales grew 10% YoY to INR 2,852 crores despite challenging operating environment. - Animal Nutrition delivered strong performance (revenue ▲12.6%, segment results ▲29%). - Oil Palm revenue grew ▲28.9%, segment results ▲14.4%; targets high single-digit to early double-digit FFB volume growth over next 4-5 years, with new integrated facilities expected to add ~200bps to overall EBITDA profile. - Astec LifeSciences achieved EBITDA breakeven (vs. INR 11 Cr loss in Q1 FY26); full-year revenue growth guidance raised to "at least more than 20%". - Crop Care business was impacted by delayed monsoon (revenue ▼16.2%), but management expects recovery in H2 due to new product launches (Ashitaka, Takai, Ghassnash) and improved weather patterns. - Dairy & Frozen Foods is undergoing strategic transformation, with Yummiez volumes ▲22% and planned degrowth in live bird business to focus on B2C value-added products. - Management is confident of achieving overall double-digit growth for FY27.

- Audio recording of the Conference Call with Investors & Analysts held on Thursday, August 6, 2026, at 3:30 p.m. (IST) is now available. - The recording can be accessed on the company's website at the provided weblink.

- The 35th Annual General Meeting (AGM) was held on August 5, 2026, via Video Conferencing. - Shareholders adopted the financial statements for FY26 and approved a final dividend of ₹11 per equity share (110%) for FY26. - Re-appointments of Ms. Nisaba Godrej and Mr. Pirojsha Godrej as Directors were approved. - Remuneration for Cost Auditors and the appointment of Mr. Burjis Godrej as Chairperson & Executive Director were also approved. - All 6 resolutions were passed with the requisite majority.

- Consolidated Sales ₹2,852 crore vs ₹2,603 crore (▲9.6% YoY) - Profit Before Tax (PBT) ₹172 crore vs ₹188 crore (▼8.5% YoY)

- Consolidated Revenue ₹2,855.22Cr vs ₹2,614.29Cr (▲9% YoY) - EBITDA ₹252.81Cr vs ₹281.98Cr (▼10% YoY) - PAT ₹128.31Cr vs ₹148.83Cr (▼14% YoY) - EBITDA Margin 8.85% vs 10.79% (▼194bps) - Mr. S. Varadaraj, Chief Financial Officer & Head - Finance & Legal, will superannuate effective September 30, 2026. - Mr. Ravishankar A. is appointed as Chief Financial Officer – Designate from September 21, 2026, and as Chief Financial Officer from October 1, 2026.

New Filing detected. See link for details.

New Filing detected. See link for details.

- Consolidated Revenue ₹2,855.22 Cr vs ₹2,614.29 Cr (▲9.21% YoY) - EBITDA ₹267.58 Cr vs ₹293.86 Cr (▼8.89% YoY) - PAT ₹128.31 Cr vs ₹148.83 Cr (▼13.78% YoY) - EBITDA Margin 9.37% vs 11.24% (▼187bps)

- Consolidated Revenue ₹2,855.22Cr vs ₹2,614.29Cr (▲9.21% YoY) - EBITDA ₹240.18Cr vs ₹269.68Cr (▼11.09% YoY) - PAT ₹128.31Cr vs ₹148.83Cr (▼13.79% YoY) - EBITDA Margin 8.41% vs 10.32% (▼191bps) - Mr. S. Varadaraj, Chief Financial Officer & Head - Finance & Legal, to superannuate early with effect from September 30, 2026. - Mr. Ravishankar A. appointed as Chief Financial Officer designate from September 21, 2026, and as CFO from October 1, 2026.

- Consolidated Revenue ₹2,855.22 Cr vs ₹2,614.29 Cr (▲9.2% YoY) - EBITDA ₹240.18 Cr vs ₹269.68 Cr (▼11.1% YoY) - PAT ₹128.31 Cr vs ₹148.83 Cr (▼13.8% YoY) - EBITDA Margin 8.41% vs 10.32% (▼191 bps) - Mr. S. Varadaraj, Chief Financial Officer & Head - Finance & Legal, will superannuate with effect from September 30, 2026. - Mr. Ravishankar A. is approved as Chief Financial Officer – Designate from September 21, 2026, and as Chief Financial Officer from October 1, 2026.

- Consolidated Revenue ₹2,852.20 Cr vs ₹2,603.32 Cr (▲9.6% YoY) - EBITDA ₹252.81 Cr vs ₹281.98 Cr (▼10.4% YoY) - PAT ₹128.31 Cr vs ₹148.83 Cr (▼13.8% YoY) - EBITDA Margin 8.86% vs 10.83% (▼197bps) - Mr. S. Varadaraj, CFO & Head - Finance & Legal, will superannuate early on September 30, 2026, due to personal reasons. - Mr. Ravishankar A. has been appointed as CFO - Designate from September 21, 2026, and will take over as CFO from October 1, 2026.